Info overloaded, consumers tune out risk info, says survey

Share this article:
Consumers tend to block out risk info in TV and print ads for prescription drugs – particularly those over age 55 – according to a study by ORC Guideline.

The research firm found that 41% of US consumers pay little or no attention to risk info presented by pharma companies in their TV commercials, and half did the same for disclosures in print ads. Respondents over the age of 55 were particularly likely to tune out risk info.

ORC Guideline's chief research officer, Morris Whitcup, said risk info overload is probably to blame. “As consumers utilize a wide variety of sources to learn about prescription medications, it may not be optimal for the FDA to require that pharmaceutical companies include the same details in each of the channels they use to communicate information about their prescription drug products,” said Whitcup.

Asked how they'd prefer to see risk information presented online, 32% said through direct links to an independent website such as WebMD, 27% opted for “a condensed version of risk disclosures a click away,” 26% a direct link to a company site and 25% a link to a government site.

The online survey of 1,045 US adults was conducted October 29-30.


Share this article:
close

Next Article in News

Email Newsletters

More in News

Astellas, DOJ settle for $7.3M

Astellas, DOJ settle for $7.3M

Astellas has settled a False Claims case with the Department of Justice over the 2010-2013 marketing of an antifungal medication. Astellas denies the allegations.

Boehringer drug lands US, EU orphan tag

Boehringer drug lands US, EU orphan tag

The experimental Breakthrough Therapy treatment is for acute myeloid leukemia.

Omnio app moves to smartphones

Omnio app moves to smartphones

Physicians Interactive is introducing the third wave of its Omnio app, making the tablet-only tool available for iPhones and Android phones.